The outer blood-retinal barrier is composed of a monolayer of retinal pigment epithelium (RPE), Bruch's membrane, and the choriocapillaris, which is fenestrated. An in vitro model that includes all these layers within a 3-D architecture confers a clear advantage over traditional monolayer cultures. Cells here, whether endothelial or epithelial, reside in conditions resembling that in vivo and can participate in cellcell and cell-matrix cross talk. This chapter describes how a human trilayer culture model was generated with RPE (ARPE-19) cells cultured on the epithelial surface of amniotic membrane and with human umbilical vein derived endothelial cells (HUVEC) on the interstitial surface. This model resembles the outer retinal barrier both in restricting transport of small molecules (<4 kDa), possession of occludin-rich tight junctions in the RPE and fenestrated endothelial cells. Techniques used to test the generated trilayer properties are also described and these include imaging of structure and molecular occupancy of tight and adherens junctions, estimation of the barrier efficiency of trilayer by measurement of fluorescein and fluorescein-conjugated tracers under flow, measurement of secreted vascular endothelial growth factor-A and ultrastructural studies, which allow analyses of the fine structure of the tight junctions in the RPE, and the endothelial fenestra.
overlying retinal pigment epithelium (RPE) as it atrophies when the RPE is experimentally removed (1) . The morphological phenotype of the choriocapillaris appears to be dictated by trophic factors secreted across the basement membrane by the RPE (2, 3) . In active neo-vascular AMD, breakdown of the outer retinal barrier and endothelial cell (EC) proliferation are key processes that lead to retinal damage and involve factors such as vascular endothelial growth factor -A (VEGF-A) (3) (4) (5) .
In this chapter, we describe techniques employed to generate a viable human in vitro model for the outer blood-retinal barrier consisting of the RPE, amnion, and human umbilical vein endothelial cells (HUVEC) (2) . This model possesses some of the key properties of the outer barrier and can be experimentally manipulated for mechanistic studies while allowing cross talk between neighbouring tissue layers.
The RPE and the choriocapillaris are separated by Bruch's membrane in vivo. The amniotic membrane can be compared to Bruch's membrane, as it consists of an inner layer of epithelial cells resting on a basement membrane (BM), which is composed of mainly type IV collagen, laminin, elastin, and heparan sulphate (6) . This BM interfaces with the vascular stroma, which consists mainly of collagen I, III, IV, fibronectin and laminin, forming an ideal extracellular matrix for cultivation of ECs. We and others have shown that the human amniotic membrane is suitable for the growth of epithelial and endothelial monolayers (2, 7, 8) . This chapter describes how placing RPE cells first on the epithelial side of the amnion and then seeding the opposite surface with ECs (see below) results in formation of a polarised RPE layer and a fenestrated endothelial monolayer. Co-cultures of RPE and bovine or human choroidal EC on transwell inserts have been attempted before (5, 9) , but the phenotypic endothelial modifications we have reported were not seen on the synthetic membranes.
Primary HUVEC is used in the trilayer since these cells have been extensively used for vascular research. They are experimentally pliable and show phenotypic plasticity ranging from formation of quiescent continuous monolayers with VE-cadherin rich adherens junctions to angiogenesis/tubulogenesis in 3-D culture (10, 11) . Moreover, isolated HUVEC continue to express signalling molecules, which respond to inflammatory mediators (12) , hypoxia, and angiogenic growth factors such as VEGF-A (11). In our generated trilayer, HUVEC show loss of fidelity of origin by becoming fenestrated (2) . Moreover, they still possess paracellular clefts with defined junctional regions, which include presence of VE-cadherin, zonula occludens (ZO)-1, and occludin (see Fig. 1 ).
In polarised epithelial monolayers, tight junctions are the key entities that seal the paracellular pathway between adjacent cells. This prevents diffusion of solutes and differentiation of the apical and basolateral membrane domains to allow active transport across the monolayer (13) . The presence of tight junctions must therefore be established in any barrier model, alongside measurements of transepithelial flux of solutes. This chapter describes some of the standard protocols used for localisation of the key structural proteins such as occludin and the cytoplasmic linking molecule ZO-1. Localization can be performed with immunocytochemistry; however, confocal laser scanning microscopes should be used for imaging the precise locations of these molecules (Fig. 1) . Tight junction (TJ) proteins such as the claudins, occludin, and junctional adhesion molecule (JAM) dictate the complexity of tight junctional strands and paracellular permeability and their expression should be ascertained (14) (15) (16) .
The tracer leakage studies are performed using a commercially available MINUCELL system, which allows the upper and lower chambers to be independently perfused with different media, under chosen flow rates. This compartmentalisation also allows frequent sampling of different compartments without disturbance of the monolayers and eliminates the unstirred layer, which can complicate tracer flux studies in static culture. Within this system, the generated model, after full confluence of both layers, excluded 95% of the transfer of 4 kDa dextran and 90% of the smaller sodium fluorescein from the upper (HUVEC chamber) to the lower chamber (RPE chamber) over a 2-h period of sampling at flow rates that do not cause shear stress (17) . The system also allows collection of culture medium from the two different compartments over the duration of culture, for later measurement of secreted growth factors by ELISA. In this in vitro 3-D model of the outer retina, VEGF-A was found to be secreted with highest measured levels being reached by 72 h in culture.
Electron microscopy studies are used to detail the TJs present between RPE in the generated model. Despite the high restrictivity to or negligent transfer of small molecules measured, ultrastructural analyses show that the TJs in the RPE do not occupy and occlude the entire length of the paracellular clefts, but are present as discrete points of apposition, more reminiscent of non-CNS endothelial tight junctions seen in vivo (18) . This may be an in vitro artefact or perhaps the addition of neural factors may lead to the formation of the archetypical tight junctional strands. Ultrastructural studies also revealed the fenestrated nature of the endothelial layer in our 3-D model. The resolution of the light microscope would not have allowed this observation, leading one to advocate, whenever possible, the addition of an ultrastructural analytical step.
In conclusion, this is a reproducible and near physiological model that mimics, with some limitations, the different layers of the back of the eye both in structure and barrier function and may be used to study the interactions between the RPE and vascular endothelium and for mechanistic investigations into development, functioning, and pathology of the outer retinal barrier. 10. Bovine serum albumin (BSA) (Sigma-Aldrich).
11. Endothelial cell growth supplement (ECGS) (First Link, Briery Hill, UK).
12. Sodium chloride (Baxter Healthcare Ltd, Thetford, UK).
13. Trigene TM (Scientific Laboratory Supplies Ltd, Nottingham, UK).
14. 1% (w/v) gelatin in sterile water, autoclaved and stored at 4°C. 2. Cryopreservation tubes (1 mL) (Sarstedt, Leicester, UK).
3. 3-way stopcocks (Vygon UK Ltd., Gloucester, UK).
4. Suture (Davies and Geck, Gosport, UK).
Container to incubate umbilical cord and steel trays (Jencons-
PLS, Leighton Buzzard, UK).
6. Cover slips (13 mm, Life Technologies).
1. Antibodies used, their source and dilution are given in Table 1. 2. Confocal laser scanning microscopy: Leica TCS-4d or Leica SP2.
3. Software: LSM 5-image analysis software.
ARPE-19 Cells

Tissue Culture Plastics and Accessories
Antibodies for Immunocytochemistry
The 13 mm MINUSHEETs (MINUCELLS and MINUTISSUE, Bad Abbach, Germany) consist of a black base ring, in which the selected support material, i.e. amnion is placed. A white tension ring is used to hold the support in place on the base ring (Fig. 2) . The MINUSHEETS optimum sterilisation method is autoclaving at 105°C and 0.3 bar for 20 min or at a maximum of 135°C and 2 bar for 10 min.
1. Anti-human VEGF-A antibody (Cat no: af-293-na, R&D Systems, UK). To 100 mg add 1 mL of sterile PBS to produce a concentration of 0.1 mg/mL. Store in 50 mL aliquots (1:250 = 0.4 mg/mL). freezer −4°C. Dilute at 1:100 = 100 ng/mL, dilute again for 2,000 pg/mL (first step of standard curve).
Recombinant VEGF-A (Cat no: 293-ve, R&D systems
3. Biotinylated anti-human VEGF-A Antibody (Cat no: baf293, R&D systems). Fifty micrograms in vial, add 1 mL of tris buffered saline + 0.1% BSA to produce a concentration of 50 mg/mL. Aliquot in 50 mL and freeze. 44 mL in 11 mL is 1:250 dilution to leave 200 ng/mL.
4. Biotyinylated-streptavidin-HRP kit (DY998, R&D systems).
5. TMB kit 50-76-00 www.kpl.com (add substrates at 1:1 less than 15 min before use).
6. Tris buffered saline: To 10 mL of 0.1% BSA, add 24.2 mg of Tris and 67.6 mg of NaCl.
7. 6% H 2 SO 4 : 6 mL of 100% H 2 SO 4 and 94 mL of dH 2 O (see Note 2).
1. Coat the culture flasks with sterile gelatin 1% (w/v) in water.
2. Use 2 mL for the 25 cm 2 culture flasks, 5 mL for the 75 cm 2 culture flasks, and 1 mL for each cover slip in an 8-well plate.
3. Incubate at 37°C with 5% (v/v) CO 2 for 30 min.
4. Remove gelatin and air-dry in a laminar flow hood under sterile conditions.
1. Immediately after clinical inspection of the placenta and umbilical cord by the midwife, transfer the amniotic membrane with chorion still attached, but removed from the placenta, to a 500-mL sterile bottle containing 200 IU/mL penicillin and 200 mg/mL streptomycin (SAL/AB). Store the bottle with the amnion at 4 o C for up to 24 h. 2. Handle the amnion and umbilical cord in a class two laminar flow hood vented to the outside, and decontaminate all surfaces that have come into contact with the tissue, cells or blood with Trigene TM as a precaution against the potential infectious elements in human tissue.
Methods
Coating Tissue Culture Plastic and Cover Slips with Extracellular Matrix Protein
Preparation of Tissues and Cells
Preparation of Amnion
3. Place the amnion in a bowl for manipulation. Under sterile conditions, process the amnion as previously described by Tseng and co-workers (19) and described below.
4. The chorion interstitial side is easily distinguishable from the epithelial surface because it is more irregular and messy. Peel the chorion carefully off the amnion with blunt dissection, making sure to remove all the interstitial material with it and leave the amnion alone behind.
5. During this process, clip one of the minusheets onto the amnion with the black side to the epithelial surface to maintain the amnion polarity. Completely remove and dispose of the chorion (see Note 3).
6. Wash the amnion repeatedly in further SAL/AB to remove all blood and protein remnants, and clip the rest of the MINUSHEETs onto the amnion.
7. Once all the clips are attached, perform careful dissection of the clips with curved scissors to produce a clean edge.
8. Place each of the clips into a sterile 12 well plate and suspend in 2 mL of SAL/AB and store overnight at 4 o C.
9. After 24 h, remove any further chorionic material that is visible by light microscopy in the laminar flow hood under sterile conditions.
10. The clips can remain in the sterile 12 well plate suspended in 2 mL of SAL/AB and stored at 4°C for up to 1 month (see Note 4).
1. Obtain umbilical cord and amnion (see Subheading 3.2.1).
2. Isolate HUVEC based on the method by Jaffe (20) .
3. Inspect the cord for any damage that could affect the isolation process or the endothelium of the umbilical vein; e.g. needle stick holes or clamp marks.
4. Blot the ends of the cord on sterile absorbable paper to dry and remove blood residues. Tease open vein at either end with forceps.
5. Cannulate the vein at either end using the 3-way stopcocks, and tie securely to prevent any leak.
6. Flush the vein three times with SAL/AB to remove blood cells and proteins. Fill vein completely to full turgor to ensure no leak or puncture marks are present and then empty.
Isolation of Human Umbilical Vein Endothelial Cells (HUVEC)
7. Fill with a 0.5-mg/mL solution of collagenase type II in Medium M0 until the vein is under pressure and close the second stopcock.
8. Incubate the cord in a water bath for 10 min at 37 o C. Using two syringes attached at the stopcocks at either end of the vein, agitate the collagenase solution back and forth through the vein to ensure that all the endothelial cells have been removed from the vessel wall.
9. Transfer the cell suspension from the syringe into a 25-mL sterile tube and centrifuge at 10 × g for 5 min.
10. Siphon off the supernatant and re-suspend the pellet in 5 mL of full medium M20 with 50 mg/mL ECGS. Seed this onto a gelatin coated flask. Incubate at 37 o C with 5% (v/v) CO 2 in air, and re-feed every 2-3 days with fresh medium.
11. Cells can be subcultured when they reached 90% confluence. 3. Observe cells rounding up and assist detachment by tapping the flask gently as previously described for HUVEC. Add Medium D10 to inhibit the action of the trypsin/EDTA, and transfer the suspension to a sterile 25 mL tube.
4. Centrifuge at 125 × g for 10 min and re-suspend the pellet in 5 mL of the D10 medium. Seed cells on to 75 cm 2 culture flasks at a split ratio of approximately 1:4 or 1:5.
5. Add Medium D10 to give a final volume of 15 mL. Cultures are maintained at 37°C with 5% (v/v) CO 2 in air, and re-fed with fresh medium every 48-72 h (see Note 6).
1. The native epithelium of the amnion can be neutralised using distilled water or remove using 4% deoxycholate for two h at 20°C (21) /mL (with 2 mL per well) onto the epithelial surface of the amnion. Wash carefully after 24 h to remove excess unattached RPE cells.
Results: The RPE cells exhibit normal epithelial morphology
when grown on the amnionitic membrane. As mono-cultures, RPE cells became confluent 24 h after seeding onto the epithelial surface of the amniotic membrane only. They show a typical columnar appearance, with no multiple layering. Cellcell contact regions show immunoreactivity to the TJ markers, occludin, and ZO-1 by 24 h but are negative for the endothelial junctional marker, VE-cadherin.
1. In a mirrored experiment to the above, the amniotic membrane in the MINUSHEET is placed into a 24-well plate (Fig. 2 ).
2. Carefully seed HUVEC cells at 1 × 10 5 /mL (with 2 mL per well).
3. Results: HUVEC exhibit the typical cobble-stone appearance and reach confluence 48 h after seeding onto the interstitial surface of the amniotic membrane only. They fail to grow on
Culture on Amnion
Culture of RPE on Amnion
HUVEC Growth on Amnion
the other surface of the membrane. Immunocytochemistry confirms full expression of the adherens junction molecule VE-cadherin at cell-cell contacts. The TJ marker ZO-1, but not occludin, is also localised to the paracellular clefts.
1. Seed RPE cells onto amnion (as described in Subheading 3.3.1).
2. After 24 h, wash the membranes to remove unattached RPE cells and turn over the minusheet (with RPE attached).
3. The cells remain bathed in epithelial medium, up to the level of the minusheet. Seed the HUVECs at 1 × 10 5 /mL onto the other (interstitial) surface and place endothelial media on to the minusheet. 4 . Wash the membrane again 24 h later to remove unattached HUVECs.
5. Once confluence has been reached (~48 h), the trilayer can be placed into a single tissue gradient carrier in the dual perfusion chamber system (Minucells and Minutissue), endothelial side up, with endothelial medium (in upper chamber) nourishing the HUVECs, and RPE medium (in lower chamber) nourishing the RPE.
6. Connect the chambers to separate reservoirs to form a closed circuit containing 25 mL media for both epithelial and endothelial circuits. Replace Medium on a daily basis. This system is amenable to both static and flow culture (see Note 8).
7. Results: RPE and HUVEC form continuous monolayers on their preferred sides of the amnion. HUVEC grow to confluence within 24 h of co-culture with RPE and amnion.
1. Transfer the trilayers contained within the MINUSHEETS from the tissue carriers to 12 well plates.
2. Aspirate the culture media, wash cells and fix with 1% paraformaldehyde at room temperature (RT) for 10 min.
3. Wash cells 3 times with normal saline.
4. Permeabilise with 0.5% Triton in PBS.
5. Block with 5% BSA in PBS for 30 min at RT.
6. Incubate with the primary antibody for 1 h at 37°C or for 24°h at 4°C.
7. Wash with PBS.
8. Incubate with the secondary antibodies for 1 h at 37°C or for 24 h at 4°C.
9. Overlay with PBS/glycerol mixed in a ratio of 1:1 (see Note 9).
Production of the Trilayer
Immunocytochemistry
10. Add Vectashield with or without Propidium iodide (if desirable to discern cell nuclei) on the slide under the trilayer and over the trilayer under the cover slip.
11. Optical images can be compiled and tilted on the x and z axes to obtain information on the extent of paracellular clefts occupied by JAMs (2).
12. Results: The co-culture conditions do not disturb the molecular phenotype of the endothelial adherens junctions since VE-cadherin is still found at cell-cell contacts throughout this period. At 24 h, HUVEC retain localisation of the TJ marker, ZO-1, with the surface expression of occludin remaining cytoplasmic. However, increased paracellular localisation of occludin is observed by 48 h, and after 72 h co-culture with RPE most of the occludin is localised to cell-cell contacts in HUVEC.
1. The trilayer can be placed into a flow culture system (Minucells and Minutissue), 48 h after seeding the HUVEC at known concentrations.
2. Flow above and below the membrane can be set to the desired flow rate. Ensure that endothelial medium is nourishing the HUVECs, and epithelial medium is nourishing the RPE.
3. Medium should be replaced on a daily basis.
1. After creating the trilayer in flow (see Subheading 3.5), 2 mL samples can be taken at the desired time points.
2. Samples should be snap-frozen and stored at −20°C until further analysis.
3. Fresh medium should only replace the sample volume (2 mL) taken at each time point.
4. Coat Maxisorp wells with capture mAb (Anti-human VEGF-A antibody, from the 50 mL aliquots) at a dilution of 1:250 in PBS and leave at 4 o C overnight. Use 100 mL per well for a 96-well plate.
Wash with PBS.
6. Block with 2% BSA for 1 h at RT.
8. Prepare a standard curve of rVEGF-A from aliquots. Dilute in 0.1% PBS/BSA at 1:100 = 100 ng/mL, dilute again 1:50 for 2,000 pg/mL (first step of standard curve). Standard curve will be from 2,000 to 31 pg/mL (maybe further) in 1:2 dilutions. Dilute samples if necessary and leave standards and samples for at least 2 h at RT or preferably at 4°C overnight.
9. Wash with PBS. 12. Add Biotinylated-streptavidin-HRP at 1: 2,000 in 1% PBS/ BSA and leave for 1 h at RT.
13. Wash with PBS.
14. Add TMB and stop with acid after 10 min or whenever the colour changes. 3. The lower chamber is bathed in the epithelial medium (as above) without tracer.
4. The chambers were connected to separate reservoirs and a closed circuit containing 25 mL media is obtained for both epithelial and endothelial circuits.
5. Samples of 200 mL can be taken at known time intervals from the lower chamber.
6. Examine fluorescence of the sample using an appropriate spectrometer, for example the Hitachi F-2000 Fluorescence Spectrophotometer.
7. The concentration of fluorescein and fluorescein-dextran in test samples are calculated by comparison against a standard concentration curve.
Results:
The Amniotic membrane alone is freely permeable to sodium fluorescein (NaF) and 4 kDa FITC-conjugated dextran. Permeability of confluent monolayers of HUVEC to 4 kDa tracers was similar or slightly reduced to that measured for amnion alone. A further reduction in the rate of tracer leakage of 4 kDa tracers was seen for RPE monocultures on amnion. These leakage values of monolayers grown on amnion show no statistical significance when compared to amnion alone. Under flow and 72 h after establishment of the trilayer, permeability to 4 kDa tracer is abolished with less
Measurement of Permeability or Tracer Flux
than 5% of 4 kDa dextran being transferred. Moreover, transfer of NaF was seen to be severely restricted in the trilayer (Fig. 3 ).
1. To fix the trilayers and monolayers of RPE and HUVEC on amnion, as well as HCE and HUVEC on amnion, use modified Karnovsky's fixative (with 2.5% paraformaldehye, 2% glutaraldehdye in 0.1 M sodium cacodylate buffer, pH 7.4). Embed in resin and process for TEM, using standard protocols.
2. Thin (70 nm) sections should be viewed with an available TEM microscope (JOEL 1010 TEM microscope in our studies).
3. Results: In our study, the appearance of fenestrae in HUVEC after 3 days of co-culture with RPE was a novel exciting finding. In vivo and in monocultures HUVEC show a continuous non-fenestrated phenotype. Thus fidelity of origin appears to be lost when co-cultured with RPE in the trilayer architecture. This was not simply a consequence of co-culture with another epithelial cell type, since tri-layering with corneal epithelial cells did not induce such a change, suggesting this is an RPE-specific cross talk (2) . The ultrastructural data highlights the usefulness of high resolution microscopy and strengthens the hypothesis that the EC phenotype (and indeed epithelial phenotype) is plastic and that its immediate environment is a more important determinant than the site of origin. 1. Store all media at 4°C and use within 4 weeks.
Transmission Electron Microscopy (TEM)
2. To make up the acid, goggles must be worn because of the exothermic nature of the reaction.
3. Maintaining the epithelial surface on the side of the black clip prevents confusion in later experiments.
4. Cryopreservation of amnion was not used (23) since freezing the amnion may produce breaks in otherwise healthy tissue that would then affect further studies, particularly the permeability studies.
5. For all RPE assays, it is recommended that the cells be used prior to passage 19 in order to maintain integrity of the phenotype. The cells should be regularly checked for phenotype by using antibodies to CRALBP.
6. For HUVEC assays, cells are used from passages 2 to 3 and are routinely checked for their endothelial nature by using antibodies to vascular specific VE-cadherin.
7. The authors prefer the use of neutralisation of the native epithelium of the amnion rather than using Thermolysin.
8. The flow system can be used to measure permeability of the trilayer to known tracers (see below).The flow rates for upper and lower chamber can be altered as necessary but if used at 0.1 mL/min, a shear stress of less than 0.25 dyne/cm 2 is present. This produces negligible shear stress for cells (17). 9. All steps are 100 mL per well. Wash with PBS containing 0.01% Tween between each step. Use 1:250 dilution (44 mL in 11 mL).
10. The reason for flow being present is also to ensure absence of any unstirred boundary layers, which would lead to an underestimation of solute flux.
